Beijing Beilu Pharmaceutical Co., Ltd. (SHE:300016)
China
· Delayed Price · Currency is CNY 9.47
-0.16 (-1.66%)
Apr 30, 2026, 3:09 PM CST
SHE:300016 Cash Flow Statement
Financials in millions CNY. Fiscal year is January - December.
Millions CNY. Fiscal year is Jan - Dec.
Fiscal Year | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2021 | 2020 - 2016 |
|---|---|---|---|---|---|---|
Period Ending | Dec '25 Dec 31, 2025 | Dec '24 Dec 31, 2024 | Dec '23 Dec 31, 2023 | Jan '23 Jan 1, 2023 | Jan '22 Jan 1, 2022 | 2021 - 2017 |
| Net Income | 88.65 | 13.65 | -71.76 | 11.28 | 125.51 | Upgrade
|
| Depreciation & Amortization | 97.31 | 94.12 | 84.46 | 77.65 | 62.83 | Upgrade
|
| Other Amortization | 5.34 | 5.93 | 3.89 | 2.86 | 1.08 | Upgrade
|
| Loss (Gain) From Sale of Assets | 1.23 | -0.12 | -0.89 | -0.1 | -0.13 | Upgrade
|
| Asset Writedown & Restructuring Costs | -43.66 | 1.14 | 33.06 | 19.77 | 0.76 | Upgrade
|
| Loss (Gain) From Sale of Investments | -8.07 | 4.59 | 7.96 | -22.99 | -28.5 | Upgrade
|
| Provision & Write-off of Bad Debts | - | -0.94 | 3.64 | -0.88 | -1.45 | Upgrade
|
| Other Operating Activities | 45.37 | 54.83 | 58.01 | 38.78 | 28.87 | Upgrade
|
| Change in Accounts Receivable | -105.11 | 38.55 | -52.91 | 33.88 | 60.4 | Upgrade
|
| Change in Inventory | -24.09 | -86.91 | 24.71 | -27.03 | -131.04 | Upgrade
|
| Change in Accounts Payable | 96.07 | 35.81 | -9.58 | 10.13 | 36.48 | Upgrade
|
| Change in Other Net Operating Assets | -4.63 | 3.46 | -4.12 | -6.94 | -40.09 | Upgrade
|
| Operating Cash Flow | 156.57 | 163.02 | 58.46 | 127.81 | 108.73 | Upgrade
|
| Operating Cash Flow Growth | -3.96% | 178.86% | -54.26% | 17.55% | -38.22% | Upgrade
|
| Capital Expenditures | -218.87 | -101.39 | -144.61 | -102.78 | -147.76 | Upgrade
|
| Sale of Property, Plant & Equipment | 0.01 | 1.67 | 21.96 | 0.01 | 0.17 | Upgrade
|
| Cash Acquisitions | -0.87 | -148.61 | - | - | - | Upgrade
|
| Investment in Securities | 4.17 | -345.62 | 4.29 | 1.35 | -24.14 | Upgrade
|
| Other Investing Activities | -31.82 | 13.18 | 4.04 | 10.21 | 27.68 | Upgrade
|
| Investing Cash Flow | -247.38 | -580.76 | -114.32 | -91.21 | -144.04 | Upgrade
|
| Long-Term Debt Issued | 518.68 | 215.85 | 323.22 | 101 | 64.71 | Upgrade
|
| Total Debt Issued | 518.68 | 215.85 | 323.22 | 101 | 64.71 | Upgrade
|
| Long-Term Debt Repaid | -361.89 | -292.14 | -219.23 | -82.03 | -219.69 | Upgrade
|
| Total Debt Repaid | -361.89 | -292.14 | -219.23 | -82.03 | -219.69 | Upgrade
|
| Net Debt Issued (Repaid) | 156.79 | -76.29 | 103.99 | 18.97 | -154.98 | Upgrade
|
| Repurchase of Common Stock | - | - | -0.1 | -3.4 | -8.38 | Upgrade
|
| Common Dividends Paid | -37.42 | -20.9 | -50.72 | -52.54 | -44.9 | Upgrade
|
| Other Financing Activities | -12.04 | - | -0 | -123.32 | 108.3 | Upgrade
|
| Financing Cash Flow | 107.34 | -97.19 | 53.17 | -160.29 | -99.95 | Upgrade
|
| Foreign Exchange Rate Adjustments | -1.82 | 0.26 | -2.52 | 0.29 | -0.19 | Upgrade
|
| Net Cash Flow | 14.7 | -514.67 | -5.21 | -123.4 | -135.45 | Upgrade
|
| Free Cash Flow | -62.3 | 61.63 | -86.15 | 25.03 | -39.03 | Upgrade
|
| Free Cash Flow Margin | -5.17% | 6.27% | -9.67% | 3.27% | -4.54% | Upgrade
|
| Free Cash Flow Per Share | -0.12 | 0.14 | -0.18 | 0.04 | -0.08 | Upgrade
|
| Cash Income Tax Paid | 76.17 | 64.22 | 45.17 | 64.27 | 63 | Upgrade
|
| Levered Free Cash Flow | -144.97 | -24.13 | -156.23 | -58.31 | -112.52 | Upgrade
|
| Unlevered Free Cash Flow | -144.97 | 12.12 | -123.02 | -28.53 | -84.91 | Upgrade
|
| Change in Working Capital | -29.61 | -10.18 | -59.91 | 1.44 | -80.24 | Upgrade
|
Source: S&P Capital IQ. Standard template. Financial Sources.